Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Biosimilars: SOP for Fed-Batch Cultivation Strategy in Bioreactor Operations – V 2.0

Posted on By


Biosimilars: SOP for Fed-Batch Cultivation Strategy in Bioreactor Operations – V 2.0


Standard Operating Procedure for Fed-Batch Cultivation Strategy in Bioreactor Operations for Biosimilars

Department Biosimilars
SOP No. SOP/BS/074/2025
Supersedes SOP/BS/074/2022
Page No. Page 1 of 13
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the process for executing fed-batch cultivation in bioreactor operations for biosimilar production, ensuring consistent cell growth, product yield, and regulatory compliance under GMP conditions.

2. Scope

This SOP applies to all fed-batch bioreactor campaigns used in mammalian cell culture for biosimilar manufacturing within the upstream processing department.

3. Responsibilities

  • Bioprocess Operators: Execute feed protocols, monitor parameters, and document observations.
  • Process Engineers: Design feed strategies and adjust based on culture performance.
  • QA Personnel: Verify adherence to batch instructions and review feed records.

4. Accountability

The Head of Upstream Processing is accountable for ensuring fed-batch protocols are implemented as per validated procedures and deviations are managed appropriately.

5. Procedure

5.1 Pre-Cultivation Preparation

  1. Ensure the bioreactor is pre-calibrated and sterile.
  2. Prepare feed solutions (e.g., glucose, amino acids, lipids) as per formulation guidelines. Filter sterilize and store under refrigerated conditions.
  3. Verify feed volumes and label feed vessels with batch number and composition (Annexure-1).

5.2 Inoculation and Batch Phase

  1. Inoculate culture at 0.3–0.5 × 106 cells/mL and monitor growth for 24–48 hours.
  2. Maintain temperature, pH, DO, and agitation as per the master batch record.

5.3 Feed Initiation

  1. Begin feeding once VCD reaches 1.0–1.5 × 106 cells/mL or glucose falls below 2 g/L.
  2. Start initial bolus feed of glucose (2%–4% final concentration) using sterile tubing or pump.

5.4 Continuous Feed Strategy

  1. Implement feed as per predetermined schedule:
    • Fixed volume daily (e.g., 10 mL/L)
    • OR exponential feeding based on cell growth and metabolic needs
  2. Monitor glucose, lactate, and ammonia levels every 12 hours.
  3. Adjust feed concentration or timing based on nutrient consumption.

5.5 DO and pH Integration

  1. Link DO feedback to agitation and oxygen cascade.
  2. Ensure feed does not result in drastic pH drift; adjust with buffers or antifoam agents as necessary.

5.6 End of Cultivation

  1. Stop feeding when VCD plateaus or viability drops below 80%.
  2. Record total feed volume and culture parameters (Annexure-2).
  3. Proceed to harvest as per SOP/BS/086/2025.

6. Abbreviations

  • VCD: Viable Cell Density
  • DO: Dissolved Oxygen
  • GMP: Good Manufacturing Practice

7. Documents

  1. Feed Solution Label – Annexure-1
  2. Feed Monitoring Log – Annexure-2

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 999 – Guidelines for Biopharmaceutical Production
  • SOP/BS/086/2025 – Harvest Process

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Feed Solution Label

Feed Type Composition Volume Batch No. Prepared By Date
Feed A Glucose 40%, Amino Acids 2L FB-074-A Rajesh Kumar 04/05/2025

Annexure-2: Feed Monitoring Log

Date Time Feed Volume (mL) Glucose (g/L) Lactate (mM) Remarks
04/05/2025 12:00 100 2.1 1.8 Normal

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Expanded section on exponential feeding and integrated DO/pH control Process Optimization
See also  Biosimilars: SOP for Cell Culture Media Optimization - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: API Manufacturing: SOP for Documentation and Review of QC Results – V 2.0
Next Post: BA-BE Studies: SOP for Controlling Noise and Environmental Disturbances – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version